Skip to main content
. 2021 Dec 21;4(12):e2139573. doi: 10.1001/jamanetworkopen.2021.39573

Figure 2. Selection Process of Immune Checkpoint Inhibitor (ICI) Randomized Phase 3 Trials From the Literature.

Figure 2.

PFS indicates progression-free survival.